A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC).

Authors :: Ozierański K
Tymińska A
Marchel M
Januszkiewicz Ł
Maciejewski C
Główczyńska R
Marcolongo R
Caforio AL
Wojnicz R
Mizia-Stec K
Grzybowski J
Gąsior M
Nowalany-Kozielska E
Pawlak A
Kaczmarek K
Żegarska J
Pączek L
Balsam P
Opolski G
Grabowski M
Source :: Cardiology journal [Cardiol J] 2022; Vol. 29 (2), pp. 329-341. Date of Electronic Publication: 2021 Dec 13.
Publication Year :: 2022

Subjects :: Biopsy
Double-Blind Method
Humans
Immunosuppression Therapy
Cardiomyopathy, Dilated
Myocarditis diagnosis
Myocarditis drug therapy

Full Text Access

Tools